CLINICAL OUTCOMES IN PEPTIDE C PRODUCTION IN TYPE 1 DIABETES PATIENTS TREATED WITH ENDOVASCULAR PANCREATIC INFUSION OF AUTOLOGOUS EXPANDED BONE MARROW MESENCHYMAL STEM CELLS AX(BM-MSC). RESULTS FROM PHASE I CLINICAL TRIAL

Arturo, J; Lucena, C; Perez, C; Castro, PJ; Gonzalez, E; Bastidas, Y; Vivas, L; Ruiz, C; Segura, O; Esteban, C; Lucena, E; Lenis, S; Dager, A

CYTOTHERAPY, 2018; 20 (5): S115